ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Vontobel Financial Products GmbH

Vontobel Financial Products GmbH (F14260)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

F14260 News

Official News Only
0 articles were found

Discussion

View Full Feed
Hosai Hosai 5 minutes ago
It was a misunderstanding as he's never updated his linked in to show works at Anavex plus they noticed his position was open on anavex jobs page but that page hasn't been updated in ages (since before he filled the vacancy).
AVXL
georgejjl georgejjl 5 minutes ago
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.090729
AVXL
Filterthenoise Filterthenoise 5 minutes ago
Fraud azz reaching deep into the bag of desperation on the market holiday🎅
RNVA
WeTheMarket WeTheMarket 6 minutes ago
Repost from Stocktwits board, courtesy of B_B_

https://www.energy.gov/lpo/nepa-related-public-involvement

https://www.energy.gov/lpo/ea-2281-draft-environmental-assessment-limestone-green-hydrogen-production-project

https://www.energy.gov/sites/default/fi
PLUG
Filterthenoise Filterthenoise 6 minutes ago
Did a key word search for "moving" Nothing showed up🎅
RNVA
Zadie420 Zadie420 6 minutes ago
What is the competition price? If you have a link to that report i greatly appreciate it. Keep in mind that CKPT got approval based on efficacy not financial cost. At the end survival is more important than the price of medicine. I am very surprised with CEO not addressing this issue.
CKPT
TrendTrade2016 TrendTrade2016 6 minutes ago
Warren Buffet has declared there is nowhere to invest at this time, except the oil and gas sector.
dewophile dewophile 6 minutes ago
RSV market opportunity:

1. The FDA this week mandated that both RSV adult vaccines carry a warning for GBS based on recently updated surveillance data showing an increase in GBS cases for both vaccines (it was something like 9 cases per million for PFE and 7 for GSK). GSK uses a lower
ENTA PFE
Investor2014 Investor2014 7 minutes ago
According to his LinkedIn profile he has never worked for Anavex - that is unless there is more than one MD PhD with that name and not on LinkedIn.

https://www.linkedin.com/in/juan-carlos-lopez-talavera-md-phd-632b924/
AVXL
Hosai Hosai 9 minutes ago
With an OLE there can't in a sense be a standard stat sig finding as there is no placebo control, you can have stat sig against ADNI but obv that would be not as robust as proper placebo controlled trial. Look at all the arguments against Cassava in regards to their open label data. However clearly
AVXL
marcis marcis 10 minutes ago
Again wrong. You projecting an opinion and incomplete information as fact once again for a negative agenda.

“bad bet” Since you don’t trade with that kind of capital, why should anyone listen to you?

Most likely the $100,000 trade buy was not a bet.
It’s rare to
RDAR
dbergh dbergh 10 minutes ago
Ask California that


Intelligence is never apart of Fox News.
Invest-in-America Invest-in-America 10 minutes ago
BAER: Hey, THANKS for that DD too, Dude!! Now I KNOW !!! (But what if they BOTH make it to ONE-HUNDRED , like Jimbo!!!??? Remember when GEORGE BURNS was 99 --- & all set for a GALA 100th Birthday Party on TV in just 2-days --- but then he suddenly CROAKED the day before the celebration???!
BAER
rolvram rolvram 11 minutes ago
NVDA could see $200b Revenue Fiscal 2026 (starting from Feb1, 2025) with Profit around $150b. P/E of 30: $4.5T Market Cap
NVDA
europa7 europa7 12 minutes ago
Top 5 NASDAQ Cybersecurity Stocks (Updated January 2025)
January 07, 2025
https://www.nasdaq.com/articles/top-5-nasdaq-cybersecurity-stocks-updated-january-2025

1. SEALSQ (NASDAQ:LAES)
Company Profile
Year-over-year gain: 475.91 percent
Market cap: U
LAES
Tree Tree 12 minutes ago
I am so glad that you are okay. I was thinking about you when I saw the news
It is extremely sad. Its hard to wrap your mind around the destruction
xodcode xodcode 13 minutes ago
Anavex should be able to hit it out of the park at JPM if they do a good job of putting it all into context and tying it to commercial goals.

It is not at all unlikely that the JPM Healthcare Conference presentation on Jan 16 will clearly and unambiguously, as suggested by both the E
JPM
rolvram rolvram 13 minutes ago
New Street Adjusts Price Target on NVIDIA to $200 From $173, Keeps Buy Rating
05:40:18 AM ET, 01/09/2025 - MT Newswires
NVDA
ddls ddls 13 minutes ago
BIEL-#1 on the most pumped stocks by pumpaholic's.😎

Little do they know the history of this pink scam.😎
BIEL
hnbadger1 hnbadger1 14 minutes ago
Not sure if it is FUD or not, but the talk on Stocktwits is that Juan Carlos Lopez-Talavera, has left Anavex.
I hope not.
AVXL
Nelson2 Nelson2 14 minutes ago
The credibility it gives BB is priceless

GLTU
BB
surfkast surfkast 16 minutes ago
Trips close this week. Verified Miro scam is over?
HIRU